Bright Minds to Present at Jefferies Conference, Grants 109,000 Options at $83.40
DRUG•Bright Minds Biosciences will present on June 3 at 4:20 PM EDT at the Jefferies Global Healthcare Conference, with a live and archived webcast available on its investor website for 30 days. The company granted 109,000 options exercisable at US$83.40 per share, vesting 25% annually over four years.
1. Jefferies Conference Presentation
Bright Minds Biosciences will present on Wednesday, June 3, 2026 at 4:20 PM EDT at the Jefferies Global Healthcare Conference. The live and archived webcast will be accessible on the company’s investor website under the events and presentations section for 30 days following the event.
2. Stock Option Grant
The company granted an aggregate of 109,000 stock options to directors, officers and consultants, exercisable at US$83.40 per share. The options vest in four equal annual installments of 25% each, commencing on the first anniversary of the grant date, and remain exercisable for five years from grant.
